Cuprina Holdings, a biomedical company specializing in chronic wound management and cosmeceuticals, has announced the pricing of its initial public offering at $4.00 per share. The firm commitment offering includes 3,000,000 Class A Ordinary Shares, aiming to raise $12 million.